Ursodeoxycholate is used to treat primary biliary cirrhosis and is incorporated into hepatocyte plasma membranes. Its steroid nucleus binds to the apolar domain of the membrane, in a similar position to cholesterol. Therefore the question arises whether ursodeoxycholate has a similar effect on membrane structure and stability as cholesterol. Using differential scanning calorimetry the thermotropic behavior of egg phosphatidylcholine and dimyristoylphosphatidylcholine were studied after incubation with cholesterol or ursodeoxycholate. Large unilamellar vesicles were prepared with cholesterol contents of 0-50%. Following incubation of these vesicles with different amounts of ursodeoxycholate, vesicle stability in a gravitational field was investigated by measuring the phospholipid and cholesterol release. Vesicle size was studied by laser light scattering after incubation with cheno-and ursodeoxycholate, and the release of entrapped carboxyfluorescein was measured by means of fluorescence spectroscopy. Increasing cholesterol diminished the enthalpy of the phase transition in the membrane. Ursodeoxycholate decreased the enthalpy of the phase transition at even lower concentrations. Lipid release from vesicles in a high gravitational field diminished with increasing cholesterol content of the vesicles. Ursodeoxycholate had a comparable effect, which increased as the cholesterol content of the vesicles was decreased. Chenodeoxycholate Ž damaged vesicles, whereas ursodeoxycholate did not. Cholesterol and ursodeoxycholate below its critical micellar . concentration decreased the carboxyfluorescein release from vesicles induced by chenodeoxycholate. Thus like cholesterol, ursodeoxycholate is incorporated into phospholipid model membranes and reduces the change in enthalpy of the gel to liquid-crystalline phase transition. Like cholesterol ursodeoxycholate also maintains membrane stability and prevents membrane damage induced by mechanical and chemical stress. q 1997 Elsevier Science B.V.
Introduction
Bile salts are potent detergents which damage cell membranes time-and dose-dependently. The efficiency with which membrane lipids, such as cholesterol and phospholipids, are solubilized in vitro generally increases with increasing bile salt hydrophobicw x ity 1-3 . Damage to hepatocyte plasma membranes by hydrophobic bile salts has been demonstrated in w x animal experiments 4,5 . Moreover, structural and functional injury of hepatocyte membranes caused by hydrophobic bile salts may play a role in the pathow x genesis of cholestatic liver diseases in man 6 . Bile salts may bind to basolateral hepatocyte membranes, to cell organelle membranes, and especially to the outside layer of the canalicular membrane following their excretion. UDC protects against damage caused w x by hydrophobic bile salts 7,8 , which seems in part to depend on the amount of its membrane-bound w x fraction 9 .
Recently it has been shown by EPR that UDC is incorporated into the apolar domain of hepatocyte w x plasma membranes in a similar way to cholesterol 9 .
The incorporation of cholesterol molecules into phospholipid bilayers has a profound effect on the gel w x to liquid-crystalline state of the membrane 10 and this effect has been widely studied due to its relew x vance to the function of biological membranes 11 . Therefore the first aim of the present study was to investigate whether UDC influences the gel to liquid-crystalline state of phospholipid membranes in a similar way to cholesterol. When a compound is inserted into phospholipid membranes, it influences or disturbs the cooperativity of the phospholipid molecules and this is reflected in a modification of w x the endotherms or exotherms 12,13 during phase transitions, e.g., transitions from the liquid crystal to the gel state. DSC is widely employed as a method for detecting phase transitions. The area under the transition peak reflects the energy released or absorbed, and the width of the curve indicates the number of molecules that undergo transition simultaneously.
The second aim of the study was to investigate the stabilizing properties of UDC, cholesterol and phospholipids on phospholipid-rich LUV. This was studied by measuring the release of CF entrapped in the vesicles and by determining the vesicle size by laser light scattering following incubation with CDC and UDC. In addition the lipid release from the membranes was measured following centrifugal forces. If UDC stabilizes membranes to a similar extent as cholesterol, this could be one of the modes of action by which UDC protects basolateral hepatocyte membranes in animal experiments and in vitro. . tler Instrumente AG, Greifensee, Switzerland . Baseline fluctuations were below "1 mW at a heating rate of 10 K min y1 with no peaks or shifts greater than 0.1 mW. Scans were run at rates of dTrdts 3 K min y1 . Enthalpy changes were determined by means of a microcomputer which was integrated into the TA 3000rDSC 30 system. Scans were recorded with a Ž . printer type PSM MK II Print swiss matrix . The Ž . transition temperature T is given in 8C. For further c characterisation of the transitions the change in en-Ž w x . thalpy DH KJrmol and the broadening of the Ž w x transition peak expressed as DD the width mm at w x. half maximum heightrmax height mm were plotted against the molar concentration of the respective Ž . addition cholesterol, UDC .
Material and methods

Ž
Samples were prepared from stock solutions of 100 mg EYLrml chloroform, 40 mg cholesterolrml chloroform, 2 mg UDCrml methanol. Appropriate amounts were collected to give molar ratios of Ž cholesterolrEYL: 0r100, 10r90, 20r80 corre-. sponding to 0, 10, 20% cholesterol , and UDCrEYL: ( ) S. Guldutuna et al.r Biochimica et Biophysica Acta 1326 1997 Ž 0r100, 5r95, 10r90, 15r85, 20r80 corresponding . to 0, 5, 10, 15, 20% UDC , two series of experiments were performed. Thereafter the solutions were dried Ž . down in DSC pans aluminium, V s 40 ml under a stream of nitrogen. After evaporation under vacuum for at least 20 h, lipid mass was gravimetrically Ž determined using an electronic microbalance Mettler . M3 . Absolute mass was determined to be 3-4 mg. Ž Ž 20 ml buffer 10 mM sodium phosphate buffer pH . . 7.4 , 0.9% NaCl, 50% glycerin was added and the pans were sealed. For complete hydration and equilibration the pans were kept at 408C for 24 h. Reference pans, containing 20 ml of the above buffer, were handled in the same manner. 50% glycerin was added to the buffer as antifreeze. In order to eliminate influences of the antifreeze reagent on the phase transition the concentration was kept constant. Heating curves were driven from y408C to q408C, cooling curves from q408C to y408C.
In addition the effect of UDC on the phase transition of dimyristoylphosphatidylcholine was investigated. The lipid was mixed with the bile salt to give molar ratios of UDCrdimyristoylphosphatidylcholine: 0r100; 0.1r99.9; 0.5r99.5; 1r99; 3r97; 5r95. The procedure described above for DSC measurements was performed, but without adding of antifreeze. Heating curves were driven from 28C to 458C and cooling curves from 458 to 28C.
Bile salt solutions
The sodium salts of bile acids were dissolved in Ž . sodium phosphate buffer 1 mM, pH 7.4 . UDC and CDC were prepared in concentrations of 0.05-10 mM; if necessary the pH was adjusted to 7.4.
Vesicle preparation
EYL and cholesterol were dissolved in chloroform, the lipid concentration was 20 mgrml solvent. Molar ratios with a cholesterol content of 0-50% were w x prepared 14 . 1 ml of the lipid solution was freezedried and the lipid film was dissolved in 0.1 mM Ž . sodium phosphate buffer pH 7.4, 258C . After freeze-thawing 10 times the suspension was passed 20 times through a polycarbonate filter of a defined Ž . Ž tm pore size 100 nm using an extruder LiposoFast , . Avestin Inc., Ottawa, Canada . Vesicle size was de-Ž R, termined by laser light scattering Coulter Nanosizer . details see below . Vesicles were freshly prepared for each experiment.
Determination of Õesicle stability
Vesicle stability against centrifugal forces was determined using ultracentrifugation. 100 ml of vesicles containing different amounts of cholesterol were incubated with 3 ml of different bile salt solutions Ž UDC and CDC, 0.1-10 mM in sodium phosphate . buffer, pH 7.4 at 258C. The suspension was shaken gently every 10 min. After 30 min the sample was centrifuged at 100 000 = g for 30 min. Phospholipid and cholesterol concentrations were determined pho-Ž . tometrically Boehringer-Mannheim Test-Kit in the suspension and in the supernatant. The lipid release Ž . concentration in the supernatant was calculated as the percentage of the total lipid concentration. LUV in buffer served as the control.
Influence of bile salts on Õesicle size
10 ml of vesicle suspension were incubated with Ž 250 ml UDC or CDC 0.1-10 mM in sodium phos-. phate buffer, pH 7.4, 258C for 10 min. The size of the vesicles was determined by laser light scattering Ž R . Coulter Nanosizer . The lower detection limit was 20 nm and the upper limit was 1000 nm, detection time was 1 min.
Determination of carboxyfluorescein-efflux
Ž . EYL 20 mgrml were dispersed in sodium phos-Ž . phate buffer 10 mM, pH 7.4 ; 6-CF was added to a final concentration of 100 mM in the buffer. Since this lipid-CF solution would not pass through the polycarbonate filter due to the high viscosity, the Ž liposomes were prepared by probe sonication Bran-. son Sonifier . Suspensions were sonified 6 times on ice for 5 min under a continuous stream of nitrogen. The CF in the extravesicular space was removed by Ž . gel chromatography Sephadex-G 50 . After centrifugation of the vesicle loaded columns at 10 000 = g w x for 10 min, the eluate was collected 15 . The procedure was repeated 4 times, until the CF was removed.
Ž . 2 ml bile salt solution CDC or UDC were mixed with 5 ml of the vesicle solution. The size of the ( ) sonicated vesicles were checked by laser light scattering and found to be 90 " 20 nm.
The fluorescence intensity I was monitored at 516 Ž . nm excitation at 492 nm on a Hitachi 650-10S fluorescence spectrometer. The self quenching effect of CF could be excluded, since the concentrations used for detection were far below the quenching w x concentrations 15 . The intensity of the total amount Ž . of CF I s 100% value was determined after complete destruction of the liposomes with 100 ml of a Ž . Triton X-100 solution 10% vrv . The percentage of w x CF released was calculated as follows 15 : %CF ŽŽ . Ž .. releaseds It-Io r I -Io = 100, where t and o refer to the time of sampling and to the instant when bile salt solution was added to the liposomal suspension. The values of CF efflux after 60, 120 and 240 sec were calculated as % of the total CF fluorescence intensity.
Reproducibility of data
All data shown are mean " standard error of at least 3 individual measurements.
Results
DSC measurements
As has previously been described, increasing the cholesterol content diminished the enthalpy of the w x phase transition of the membrane 10 . Table 1 . The width of the transition peak became broader with increasing amounts of cholesterol. 20% cholesterol resulted in a maximum Ž broadening of the peak DD s 1.59 heating scans, . DD s 1.68 cooling scans with a 53% reduction of enthalpy in heating scans and 55% reduction in cooling scans. The data obtained from the heating and the cooling scans were similar, although the transition temperature was lower for the cooling curve.
Addition of UDC to EYL resulted in a very similar behavior of the phase transitions. The enthalpy of the transition was decreased by the addition of UDC, even at concentrations of 5-20 mol%. Increasing the amount of UDC to 20% led to a further decrease in DH; in the cooling scans by about 55%, and in the heating scans by about 50%. The change in T was c not significant and was in the range of y9 to y108C for the heating scans and y12 to y138C for cooling Ž . scans. Increased peak broadening DD was marked Ž . at concentrations of 20% UDC Table 1 .
Addition of UDC to dimyristoylphosphatidylcholine reduced the enthalpy of the transition even at concentrations of 0.1 mol%. The effect on peak Ž . broadening DD could be observed at concentrations of 3%. T was 22.58C, addition of 5% UDC led only c to a minimal change in transition temperature to Ž . 20.38C Table 1 , Fig. 1 .
Stability of Õesicles
The vesicles used were LUV, data obtained by laser light scattering have shown a homogeneous Ž suspension with a size of 100 " 10 nm polydisper-. sity index 3 prior to centrifugation. After centrifugation the supernatant was investigated by laser light scattering, particles less -20 nm in size could be detected. These particles were only induced by centrifugal forces. The stabilizing effect of cholesterol in LUV against centrifugal forces to the vesicles is seen Ž . in Fig. 2 curve 1 . Increasing the cholesterol content of the membrane reduces the phospholipid release. The greatest stabilizing effect was found with membranes containing 40% cholesterol, which reduced the phospholipid release from 44.3 to 11.5%. A further increase in membrane cholesterol did not further enhance the stability of the vesicles since the phospholipid release then increased to 12.5%. The cholesterol release induced by centrifugal forces was also decreased by increasing the membrane cholesterol Ž . Fig. 3 , curve 1 . The most marked effect was found Ž with 40% membrane cholesterol cholesterol release . 10.6% ; in membranes with 10% cholesterol the release was 42.7%.
Similar results were found when the membrane lipid release from LUV was measured after incubation with UDC. The greatest effect of UDC on membrane stabilization was found when 100% EYL vesicles were incubated with 3 mM UDC: a reduction in the phospholipid release from 44.3 to 12.2% was Ž . observed Fig. 2 .
Vesicle pelleting by bile salts could be excluded since in control experiments with 3 mM CDC the phospholipid release in the supernatant increased from 44.3 to 91.6%. In addition UDC was used in concentrations below the CMC excluding formation of lipid aggregates. 
Ž
. UDC also prevented cholesterol release Fig. 3 . In vesicles containing 10% cholesterol, the cholesterol release was reduced from 42.7% to 23.1% by incubation with 0.1 mM UDC. UDC concentrations up to 3 mM reduced cholesterol release to 12.8%. Vesicles with a cholesterol content over 30% were not further 
. stabilized by UDC Fig. 3 . Increasing the UDC Ž . concentration Fig. 7 above the CMC increased the phospholipid release to 33.8% in 100% EYL vesicles Ž . control value 44.3% , indicating that UDC has no effect on phospholipid and cholesterol release above w x the CMC of about 5.5 mM 15 .
Determination of Õesicle size
The mean size of control vesicles measured by Ž laser light scattering was 100 " 10 nm polydisper-. sity index 3 . An increase in vesicle size of 50-100% was detected after incubation with CDC in a concentration just below that required for vesicle solubiliza-Ž . tion Fig. 4 , indicating that the bile saltrlipid ratio in the membrane is increased. 100% EYL vesicles were solubilized by concentrations of 1.1-1.25 mM CDC, i.e., vesicle size was reduced below 20 nm. When the cholesterol concentration of the vesicles was gradually increased, the CDC concentration required for membrane solubilization also increased. In vesicles containing 40% cholesterol, membrane solubilization was found at CDC concentrations of 1.4-1.5 mM. Cholesterol concentrations above 40% did not further increase membrane stability.
In incubation experiments with UDC the size of 100% EYL vesicles remained constant up to concen- Fig. 6 . CF release from LUV with EYL and different cholesterol concentrations induced by UDC. Incubation time with bile salts: 60 sec. Mean standard error of triplicate measurements: curve for 100% EYL s"6.5.; curve for 10% Chols"4.0; curve for 20% Chols"4.5; curve for 30% Chols"3.1; curve for 40% Chol s"5.9; curve for 50% Chols"7.7.
( ) trations of 5 mM UDC. Above this concentration vesicle size increased dramatically and vesicle aggre-Ž gation possibly with the formation of multilamellar . vesicles could be detected with a size greater than Ž . 1000 nm Fig. 4 , the polydispersity index was 5. By increasing the cholesterol concentration vesicle aggregation was shifted to higher UDC concentrations Ž . 7.5 mM UDC .
CF efflux
In preliminary experiments we investigated the effect of bile salts on CF efflux for incubation times up to 60 min. Equilibration of the system was reached after 4-5 min, longer incubation times revealed no more information on membrane permeability. The most dramatic changes in membrane permeability could be observed in the first minutes during bile salts incubation. The percentage of CF in the supernatant after 60, 120 and 240 s incubation with CDC and UDC revealed a time-dependent increase of CF efflux from EYL vesicles. In 100% EYL vesicles CDC induced 10% CF efflux even at concentrations below 0.05 mM. The CF efflux depended on the Ž . cholesterol concentration of the vesicles Fig. 5 . Increasing the cholesterol concentration decreased the CF efflux. This effect was found up to cholesterol concentrations of 40%. At cholesterol concentrations above 40%, the CF efflux caused by bile salts increased again. Ž . Fig. 7 . Influence of UDC on 100% EYL-LUV: 1 On vesicle Ž . Ž . size, 2 on phospholipid release and 3 on CF release. Mean Ž . standard error of triplicate measurements: curve 1 s"21; curve Ž .
Ž . 2 s"3.9; curve 3 s"6.5.
Ž .
Ž . Below 4 mM UDC induced only minor CF release Ž . occurred from 100% EYL vesicles Fig. 6 . Incubation with 2 or 3 mM UDC induced a CF release of 9-18%. In concentrations below the CMC of UDC, vesicle size remained constant and membrane lipids Ž . were not released Fig. 7 . However, a distinct re-Ž . lease of CF 80% and more was observed with Ž . concentrations above 4 mM UDC Figs. 6 and 7 .
The release of CF from 100% EYL vesicles induced by 0.1 mM CDC was ) 80% inhibited by Ž . incubation with 0.1 mM UDC Fig. 8 . A similar effect could be achieved by increasing the membrane Ž . cholesterol Fig. 5 . The inhibitory effect of UDC Ž was not seen in vesicles containing cholesterol data . not shown .
Discussion
By means of electron paramagnetic resonance spectroscopy and with radioactively labelled bile salts, it has been shown that UDC is incorporated into w x w x hepatocyte plasma membranes 9 and LUV 16 . The steroid nucleus of UDC is located in the apolar part of the lipid bilayer decreasing membrane polarity and preventing membrane damage caused by hydrophobic ( ) bile salts. Since in isolated cell membranes UDC w x molecules occupy a similar position to cholesterol 9 , the aim of the present study was to compare the effects of UDC and cholesterol on membrane stabilization using large unilamellar vesicles as a membrane model.
Cholesterol is known to reduce the enthalpy of the w x phase transition of phospholipid membranes 10,13 . DSC revealed an effect of UDC on the phase transition that was comparable to that of cholesterol. Both compounds progressively reduced the enthalpy of the transition as their concentrations were increased. Enthalpy was reduced by about 50% when the UDC:phospholipid or cholesterol:phospholipid ratio in the model membranes was as low as 1:5. In these experiments glycerol was added as antifreeze, because of the low transition temperature of the lipid. In experiments with dimyristoylphosphatidylcholine, however, the effect of antifreeze on the phase transition was excluded and again an inhibitory effect UDC on the enthalpy of the phase transition could be observed, even at concentrations of 0.1%. w x In DSC studies with taurocholate 17 and tauw x rodeoxycholate 18 the transition temperature of DPPC was changed, indicating that micellar structures affecting the cooperativity of the lipid. On the contrary UDC did not change under our experimental conditions the transition temperature of the lipid. Cholesterol interacts with membranes and affects their thermotropic properties by inserting into the hydrophobic part of the membrane. This leads to a broadening, a reduction, or an elimination of the phase transition without altering the phase transition temperature as has been previously reported in the w x literature 13, 19 . The thermal behaviour of a lipid is an important factor in the permeability, fusion and w x protein binding of lipid membranes 11,20 . The similar effects of UDC and cholesterol on the phase transition therefore indicate that these substances may interact with lipids in a similar fashion. UDC interacts with membrane lipids, ordering the chains and w x decreasing their motion as does cholesterol 21 . We were unable to obtain data on order parameters using EPR, since it was not possible to remove the bile salts from the vesicle containing suspension without destroying the membranes and previous studies have shown that bile salts interact with lipid spin labels. However, if bile salts are removed from the super-natant, UDC decreases membrane polarity and fluidw x ity 9 . Thus the DSC experiments complement our EPR investigations.
Interactions between bile salts and phospholipid membranes have also been described for C, DC and w x w x CDC 22,23 . By means of NMR experiments 22 it has been shown that C molecules are most probably placed flat on the membrane surface rather than intercalated between the phospholipid molecules. However, deuterated DC and CDC, were found to be incorporated perpendicularly into the surface of the w x lecithin bilayer membrane 23 . The effect of bile acids on membranes is induced by membrane binding w x 16 . The protonated form of the bile acids in the w x membranes depends on the pKa 16,24 , more polar bile acids, e.g., taurine conjugated are expected not to be protonated in the membrane. The pKa of UDC is w x higher than CDC 25 and in membranes is increased w x by several pH units 24 . Under the experimental conditions used in this study UDC is expected to be protonated and membrane-bound. The steroid nucleus of UDC is located in the center of the bilayer, the polar carboxyl group oriented towards the aqueous phase, while glyco-and tauroursodeoxycholate are located in the interface, oriented with their polar side w x chains on the membrane surface 9 . Since UDC is a relatively hydrophilic bile salt as estimated with reversed phase high performance liquid chromatography, incorporation could occur as a paired molecule, thereby avoiding contact between its polar groups w x and the fatty acid chains of the membrane 26 .
Cholesterol is incorporated into the membrane with its hydroxyl group oriented to the aqueous surface and the aliphatic chain aligned parallel to the acyl w x chains in the center of the bilayer 11,20 . The steroid nucleus is positioned along the first ten carbons of the phospholipid chain. EPR studies suggest that the steroid nucleus of UDC is located a few atoms deeper than that of cholesterol, but in principle in the same w x domain 9 .
Although the steroid nucleus of UDC and cholesterol are localized in the same domain of the plasma membrane and decrease membrane fluidity, incubation of CF loaded vesicles with UDC below the CMC induces slight CF release of about 4-18%. However, by measuring the vesicle size, the polydispersity index and the phospholipid release from the membranes, a disruption of the vesicles and the formation ( ) of mixed phospholipidrbile salt micelles was ex-Ž . cluded Fig. 6 . It has been suggested that during incubation of vesicles with bile salts, the number of molecules in the outer leaflet of the bilayer increases, and that the difference in the number of molecules in the outer and inner leaflet results in a sudden membrane foldover accompanied by a transient pore forw x mation 16 . After redistribution of UDC in both leaflets of the bilayer, membranes were rapidly stabilized and the CF release ceased. This could be an explanation for the CF release in our experiments. In the case of CDC, membrane foldover and pore formation may also be caused by interactions between the hydroxygroups of the steroid nucleus.
CDC above the CMC solubilizes phospholipid membranes to form mixed micelles with membrane w x lipids 27 , whereas low concentrations of UDC stabilize LUV membranes as does cholesterol. The stabilizing effect of UDC was inversely correlated to the cholesterol content of the membrane. No effect of UDC was observed in vesicles with a membrane cholesterol content of 30% and more. This phenomenon may be due to the condensation of the membrane by cholesterol molecules reducing the fluidity of the phophoslipid layers above the phase w x transition temperature 11,20 , thus preventing the w x penetration of bile salt molecules 16 . w x Previous investigators 28 have described a protective effect of tauroursodeoxycholate in concentrations of up to 15 mM against the damaging effect of taurodeoxycholate on vesicles containing 50% w x cholesterol. Above the CMC 29,30 we obtained Ž . similar data not shown for UDC. Above the CMC UDC induced fusion of vesicles to multilamellar Ž . aggregates Fig. 7 . Lipid aggregation was also shown w x for taurocholate above the CMC 31 . This phenomenon may be induced by the formation of apolar clusters on the membrane surface. Above a cholesterolrlipid ratio of 1, cholesterol also induced vesicle w x fusion 21 .
In low concentrations CDC increased the permeability of the vesicles as shown by the CF release. UDC also had a protective effect against CDC damage, when vesicles were incubated in an equimolar Ž . UDCrCDC-solution 0.1r0.1 mM . This effect could be due to a molecular interaction of bile salts in the w x buffer milieu, as shown previously 9 , or UDC could impede the penetration of CDC into the inner leaflet of the bilayered membrane. The latter may be more likely, since if the effect were merely a molecular interaction in the incubation medium, the inhibition of the CF release should be independent of the lipid composition of the vesicles. However, since there was no relevant inhibition of CF release by UDC in cholesterol containing vesicles, a direct membrane effect can be assumed. As shown above, this direct membrane effect of UDC is inversely correlated to the cholesterol concentration of the vesicles inhibitw x ing the insertion of UDC 16 . Thus membrane-bound UDC impedes the penetration of cholesterol into the membrane.
The similarities between UDC and cholesterol concerning their interaction with phospholipid membranes may be of relevance for the therapeutic effect of UDC. In cholestatic liver diseases liver plasma Ž membranes especially canalicular hepatocyte mem-
. w x branes may change their lipid composition 32 , since during cholestasis the more hydrophobic 'toxic' bile salts seem to accumulate around the bile capillarw x ies 33,34 . Since bile secretion in these patients is reduced and retention of the more apolar, toxic bile salts into blood occurs, similar alterations may occur at basolateral hepatocyte membranes. One of the therapeutic effects of UDC could be the maintenance of membrane structure, stability and function.
